Clinical trial
Exemestane and Celecoxib in Postmenopausal Women at High Risk for Breast Cancer
NCT00073073 · Georgetown University, Other · Completed
Key facts
| NCT number | NCT00073073 |
|---|---|
| Title | Exemestane and Celecoxib in Postmenopausal Women at High Risk for Breast Cancer |
| Official title | A Trial of Exemestane in Postmenopausal Women With DCIS or at High Risk for Invasive Breast Cancer |
| Lead sponsor | Georgetown University, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Breast Neoplasms |
| Intervention type | Dietary Supplement, Drug |
| Interventions | Exemestane, Calcium carbonate, Vitamin D |
| Enrollment | 46 |
| Start date | Nov 1, 2003 |
| Primary completion | Dec 1, 2011 |
| Completion | Dec 1, 2011 |
| First posted | Nov 17, 2003 |
| Last update posted | May 17, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: